| D007410 |
Intestinal Diseases |
Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM. |
Disease, Intestinal,Diseases, Intestinal,Intestinal Disease |
|
| D009504 |
Neutrophils |
Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. |
LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil |
|
| D010851 |
Picrates |
Salts or esters of PICRIC ACID. |
|
|
| D005609 |
Free Radicals |
Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. |
Free Radical |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D006834 |
Hydrazines |
Substituted derivatives of hydrazine (formula H2N-NH2). |
Hydrazide |
|
| D000636 |
Aminosalicylic Acids |
A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions. |
Acids, Aminosalicylic |
|
| D001095 |
Arachidonic Acids |
|
Eicosatetraenoic Acids,Acids, Arachidonic,Acids, Eicosatetraenoic |
|
| D001713 |
Biphenyl Compounds |
Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. |
Compounds, Biphenyl |
|
| D012460 |
Sulfasalazine |
A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) |
Salicylazosulfapyridine,Asulfidine,Azulfadine,Azulfidine,Azulfidine EN,Colo-Pleon,Pleon,Pyralin EN,Salazopyrin,Salazosulfapyridine,Sulfasalazin medac,Sulfasalazin-Heyl,Sulfasalazine FNA,Sulphasalazine,Ucine,Ulcol,ratio-Sulfasalazine,Colo Pleon,Sulfasalazin Heyl,ratio Sulfasalazine |
|